Ajax-Loading

Hansoh Pharmaceutical Group Co Ltd - Capital Expenditures

Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Capital-Expenditures" stands at 0.2863 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 06/30/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 29.10 percent compared to the value the year prior.
The 1 year change in percent is 29.10.
The 3 year change in percent is -51.51.
The 5 year change in percent is -58.49.

The Serie's long term average value is 0.607 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 52.85 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2024, to it's latest available value, on 06/30/2025, is +37.82%.
The Serie's change in percent from it's maximum value, on 12/31/2020, to it's latest available value, on 06/30/2025, is -86.38%.

Capital Expenditures for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Capital Expenditures905,699,262,464.00
LogoJohnson & Johnson - Capital Expenditures486,508,953,600.00
LogoAbbVie Inc - Capital Expenditures399,570,305,024.00
LogoRoche Holding AG - Capital Expenditures317,433,206,677.55
LogoAstraZeneca PLC - Capital Expenditures280,205,508,085.11